Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.38 |
| ▸ | CES2 | O00748 | 6/20 | 0.38 |
| ▸ | CES1 | P23141 | 6/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL217658 | 0.91 | MAPT (0.47) | ACHECES2CES1MEN1KMT2A | |
| SCHEMBL217696 | 0.89 | RAB9A (0.41) | ACHECES2CES1MEN1KMT2A | |
| SCHEMBL218279 | 0.88 | CES2 (0.37) | ACHECES2CES1MEN1KMT2A | |
| SCHEMBL217788 | 0.84 | MEN1 (0.37) | ACHECES2CES1MEN1KMT2A | |
| SCHEMBL217009 | 0.84 | MAPT (0.46) | ACHECES2CES1MEN1KMT2A | |
| SCHEMBL5699058 | 0.73 | RAB9A (0.56) | ACHEMEN1KMT2AMAPTNPC1 | |
| SCHEMBL3661065 | 0.73 | TRPA1 (0.52) | MEN1KMT2AMAPTNPC1RAB9A | |
| SCHEMBL8437177 | 0.72 | ALDH1A1 (0.47) | ACHECES2CES1MEN1KMT2A | |
| SCHEMBL8437175 | 0.72 | ALDH1A1 (0.47) | ACHECES2CES1MEN1KMT2A | |
| SCHEMBL11767203 | 0.70 | NPC1 (0.41) | MEN1KMT2AMAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060063105-A1 | Negative-working photoimageable bottom antireflective coating | OBERLANDER JOSEPH E | 2006-03-23 | — | — | US | claimed |
| EP-1466214-A2 | NEGATIVE-WORKING PHOTOIMABEABLE BOTTOM ANTIREFLECTIVE COATING | AZ Electronic Materials USA Corp. (US) | 2004-10-13 | — | — | EP | claimed |
| US-20030215736-A1 | Negative-working photoimageable bottom antireflective coating | AZ ELECTRONIC MATERIALS USA CORP. | 2003-11-20 | — | — | US | claimed |
| WO-2003058345-A2 | NEGATIVE-WORKING PHOTOIMAGEABLE BOTTOM ANTIREFLECTIVE COATING | CLARIANT INTERNATIONAL LTD (CH) | 2003-07-17 | — | — | WO | claimed |
| US-8088548-B2 | Bottom antireflective coating compositions | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2012-01-03 | — | — | US | disclosed |
| EP-2212273-A2 | BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS | AZ Electronic Materials USA Corp. (US) | 2010-08-04 | — | — | EP | disclosed |
| WO-2009053832-A2 | BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS | AZ ELECTRONIC MATERIALS USA CORP. (DE) | 2009-04-30 | — | — | WO | disclosed |
| US-20090104559-A1 | Bottom Antireflective Coating Compositions | MERCK PATENT GMBH (DE) | 2009-04-23 | — | — | US | disclosed |
| US-20060063105-A1 | Negative-working photoimageable bottom antireflective coating | OBERLANDER JOSEPH E | 2006-03-23 | — | — | US | disclosed |
| EP-1466214-A2 | NEGATIVE-WORKING PHOTOIMABEABLE BOTTOM ANTIREFLECTIVE COATING | AZ Electronic Materials USA Corp. (US) | 2004-10-13 | — | — | EP | disclosed |
| US-20030215736-A1 | Negative-working photoimageable bottom antireflective coating | AZ ELECTRONIC MATERIALS USA CORP. | 2003-11-20 | — | — | US | disclosed |
| WO-2003058345-A2 | NEGATIVE-WORKING PHOTOIMAGEABLE BOTTOM ANTIREFLECTIVE COATING | CLARIANT INTERNATIONAL LTD (CH) | 2003-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104559-A1 | Bottom Antireflective Coating Compositions | SDC2, S100A9, MYH9 | ACHE 3212/4885CES2 3197/4885CES1 3825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.